Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ARIAD Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (427)	1/7/1999 2:14:00 AM
From: Mike McFarland	Respond to of 4474

The Jan 11 issue of TIME is a special issue with a relatively large section called "The future of medicine...how genetic engineering will change us in the next century" If you can get through all the Pfizer adverts, go to the "Fixing the Genes" article which begins on page 68. There is a brief discussion of AAV therapy on page 70--last paragraph, save yourself a few bucks and read it in line at the grocery store, heh heh. Read on and you get a little blurb about lentivirus. I am encouraged that very little of what I read in TIME was news to me...so I expect you will find it positively banal. Like I said, read it in line. (Sorry TIME, if you don't plug my stocks, I wont plug your mag). Have not read everything yet, maybe I'll find something yet. Oh, I re-established a "one third" position in Ariad ...I was thinking it might sag to $2, but the chart looks pretty flat here now, and the volume is not bad. --MM